PubRank

R H Myers

Author PubWeight™ 183.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997 17.88
2 Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 2000 8.84
3 Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985 7.93
4 CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997 4.01
5 Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998 3.89
6 Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med 1988 3.82
7 The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987 3.59
8 CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 2012 3.12
9 Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 1990 2.80
10 Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991 2.70
11 Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 2001 2.54
12 Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996 2.49
13 Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000 2.49
14 Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum 1998 2.45
15 Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1984 2.31
16 Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 2008 2.16
17 Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A 2003 2.15
18 Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg 1999 1.94
19 Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet 2000 1.94
20 Factors related to onset age of Huntington disease. Am J Hum Genet 1982 1.93
21 Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology 2002 1.90
22 Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet 2007 1.86
23 Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992 1.84
24 Weight loss in early stage of Huntington's disease. Neurology 2002 1.79
25 Parental age at child's birth and son's risk of prostate cancer. The Framingham Study. Am J Epidemiol 1999 1.77
26 Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 1987 1.75
27 A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study. Diabetologia 2003 1.72
28 Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994 1.71
29 Huntington disease: no evidence for locus heterogeneity. Genomics 1989 1.70
30 Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum. Hum Mol Genet 1995 1.67
31 Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989 1.65
32 Maternal transmission in Huntington's disease. Lancet 1983 1.64
33 Heritability of left ventricular mass: the Framingham Heart Study. Hypertension 1997 1.63
34 Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology 1999 1.60
35 Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med 2001 1.60
36 Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: the Framingham Study. J Bone Miner Res 2002 1.58
37 Estimation of morbid risk and age at onset with missing information. Am J Hum Genet 1991 1.56
38 The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD. Am J Hum Genet 1993 1.55
39 Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol 2000 1.54
40 Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinaemia. Lancet 1998 1.44
41 Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol 2001 1.44
42 Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999 1.42
43 Maternal factors in onset of Huntington disease. Am J Hum Genet 1985 1.39
44 Familial aggregation of stroke. The Framingham Study. Stroke 1993 1.36
45 Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med 1998 1.35
46 Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999 1.33
47 Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 1991 1.30
48 Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2004 1.27
49 Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol 1992 1.27
50 Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains. Neurobiol Dis 1994 1.25
51 Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology 2001 1.25
52 Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet 1991 1.25
53 Reduced penetrance of the Huntington's disease mutation. Hum Mol Genet 1997 1.25
54 Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 2000 1.19
55 Juvenile onset Huntington's disease--clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001 1.18
56 Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry 1985 1.18
57 Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 1989 1.17
58 Gametic but not somatic instability of CAG repeat length in Huntington's disease. J Med Genet 1993 1.15
59 Kynurenine pathway abnormalities in Parkinson's disease. Neurology 1992 1.14
60 Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurology 1990 1.13
61 Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb Vasc Biol 2001 1.13
62 Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting. Am J Hum Genet 1992 1.12
63 Predictors of nursing home placement in Huntington disease. Neurology 2003 1.11
64 Potential impact of a predictive test on the gene frequency of Huntington disease. Am J Med Genet 1984 1.10
65 Family patterns of coronary heart disease mortality: the Framingham Longevity Study. J Clin Epidemiol 1992 1.09
66 The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res 1997 1.07
67 Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 2001 1.06
68 A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994 1.04
69 Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology 1993 1.03
70 Huntington's disease. Cold Spring Harb Symp Quant Biol 1996 1.02
71 Segregation analysis of Parkinson disease revealing evidence for a major causative gene. Am J Med Genet 2002 1.01
72 Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord 2005 1.01
73 Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study. Ann Hum Genet 2006 1.01
74 Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology 1990 0.98
75 Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease. Genet Epidemiol 1989 0.97
76 Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 2001 0.97
77 Neocortical dendritic pathology in human partial epilepsy: a quantitative Golgi study. Epilepsia 1994 0.97
78 Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science 1987 0.96
79 Mapping of quantitative ultrasound of the calcaneus bone to chromosome 1 by genome-wide linkage analysis. Osteoporos Int 2002 0.96
80 Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 2000 0.96
81 Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: the NHLBI family heart study follow-up examination. Genes Immun 2007 0.95
82 Understanding the decision to take the predictive test for Huntington disease. Am J Med Genet 1991 0.94
83 Familial Alzheimer's disease: progress and problems. Neurobiol Aging 1989 0.92
84 Lewis blood group phenotype as an independent risk factor for coronary heart disease (the NHLBI Family Heart Study). Am J Cardiol 1999 0.91
85 A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology 2003 0.90
86 BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology 2005 0.90
87 Interaction of alpha(1)-Na,K-ATPase and Na,K,2Cl-cotransporter genes in human essential hypertension. Hypertension 2001 0.89
88 Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov Disord 1996 0.86
89 Long-term impact of Huntington disease linkage testing. Am J Med Genet 1997 0.86
90 Genetic background of Lewis negative blood group phenotype and its association with atherosclerotic disease in the NHLBI family heart study. J Intern Med 2000 0.86
91 Huntington's disease in monozygotic twins reared apart. J Med Genet 1983 0.86
92 Phenotypic variation in 2 Huntington's disease families with linkage to chromosome 4. Neurology 1989 0.86
93 Hybrid ape offspring of a mating of gibbon and siamang. Science 1979 0.85
94 Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology 2006 0.83
95 Considerations in using linkage analysis as a presymptomatic test for Huntington's disease. J Med Genet 1988 0.83
96 Effects of similarities in lifestyle habits on familial aggregation of high density lipoprotein and low density lipoprotein cholesterol: the NHLBI Family Heart Study. Am J Epidemiol 1999 0.83
97 Estimation of fertility and fitness in Huntington disease in New England. Am J Med Genet 1989 0.82
98 Huntington's disease: genetics, chemical pathology, and management. Prog Med Genet 1985 0.81
99 Family-based association tests for qualitative and quantitative traits using single-nucleotide polymorphism and microsatellite data. Genet Epidemiol 2001 0.80
100 NYD-SP18 is associated with obesity in the NHLBI Family Heart Study. Int J Obes (Lond) 2008 0.79
101 Genotype-by-sex interaction in the aetiology of type 2 diabetes mellitus: support for sex-specific quantitative trait loci in Hypertension Genetic Epidemiology Network participants. Diabetologia 2006 0.79
102 Change in attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 1986 0.77
103 Evidence for a major gene accounting for mild elevation in LDL cholesterol: the NHLBI Family Heart Study. Ann Hum Genet 1999 0.77
104 Absence of linkage for bone mineral density to chromosome 12q12-14 in the region of the vitamin D receptor gene. Calcif Tissue Int 2000 0.77
105 Discrepancy resolved. Nat Genet 1993 0.77
106 False-negative results with levodopa for early detection of Huntington's disease. N Engl J Med 1982 0.77
107 Segregation analysis for high density lipoprotein in the Berkeley data. Genet Epidemiol 1993 0.77
108 Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease. Mov Disord 1999 0.76
109 Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136-->Ser) variant in multigenerational pedigree studies. Atherosclerosis 1996 0.76
110 [Huntington disease: 7 cases with relatively preserved neostriatal islets]. Rev Neurol (Paris) 1992 0.76
111 Molecular genetics of familial Alzheimer's disease. Eur Neurol 1989 0.75
112 Interpreting plots of a multidimensional dose-response surface in a parallel coordinate system. Biometrics 1990 0.75
113 Smoking influences the association between apolipoprotein E and lipids: the National Heart, Lung, and Blood Institute Family Heart Study. Lipids 2000 0.75
114 Two-stage designs for the logistic regression model in single-agent bioassays. J Biopharm Stat 1996 0.75
115 Robust analysis of covariance. Biometrics 1982 0.75
116 Linkage map of anonymous loci near the CF gene. Prog Clin Biol Res 1989 0.75
117 Molecular genetics of familial Alzheimer's disease. Can J Neurol Sci 1989 0.75
118 Influence of marker heterozygosity and genetic heterogeneity on fine mapping. Genet Epidemiol 2001 0.75
119 Experimental designs for estimating effective doses. Clin Pharmacol Ther 1969 0.75
120 Alzheimer's disease, Down's syndrome, and aging: the genetic approach. Ann N Y Acad Sci 1982 0.75
121 Quantification of muscle tremor of Huntington's disease patients and their offspring in an early detection study. Biol Psychiatry 1979 0.75
122 No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index: the National Heart, Lung, and Blood Institute Family Heart Study. Metabolism 2000 0.75
123 Attitudes toward marriage and childbearing of individuals at risk for Huntington's disease. Soc Work Health Care 1984 0.75
124 Stratification techniques to explore genotype environment interactions. Genet Epidemiol 1999 0.75
125 Detecting linkage for a complex disease using simulated extended pedigrees. Genet Epidemiol 1997 0.75
126 An unusual cause of ocular pain. J Tenn Med Assoc 1967 0.75
127 Insulin and hypertension in the NHLBI Family Heart Study: a sibpair approach to a controversial issue. Am J Hypertens 2000 0.75
128 The speakers' platform: neglected medium. Natl Conf Dent Public Relat 1967 0.75
129 Learned aversions to intracerebral carbachol. Physiol Behav 1977 0.75
130 Segregation analysis of total nevus density and estimation of lifetime risk and average onset age of melanoma. Cytogenet Cell Genet 1992 0.75